Reporting owner

ENRIGHT PATRICK G

Reporting owner CIK 0001253886 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.ENRIGHT PATRICK GENRIGHT PATRICK GENRIGHT PATRICK G · December 11, 2025 · Purchase · Class A Common StockENRIGHT PATRICK G · October 9, 2025 · Purchase · Common StockENRIGHT PATRICK G · October 9, 2025 · Purchase · Common StockOct 9, 2025Dec 11, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 11, 2025Vera Therapeutics, Inc.Class A Common StockENRIGHT PATRICK GPurchase
Oct 9, 2025Zenas BioPharma, Inc.Common StockENRIGHT PATRICK GPurchase
Oct 9, 2025Zenas BioPharma, Inc.Common StockENRIGHT PATRICK GPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Vera Therapeutics, Inc.VERA · company listingsPurchaseClass A Common StockNon-derivative security · Code P5,88242.5Value: 249,985Currency not specifiedView ↗
Trade: Zenas BioPharma, Inc.ZBIO · company listingsPurchaseCommon StockNon-derivative security · Code P11,99020.85 *Value: 249,991.5Currency not specifiedView ↗
Trade: Zenas BioPharma, Inc.ZBIO · company listingsPurchaseCommon StockNon-derivative security · Code P105,26519 *Value: 2,000,035Currency not specifiedView ↗